Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Efficacy and Safety of Tixagevimab/cilgavimab As Passive Immunisation Against COVID-19 Infections in Patients with Hematological Malignancies

Patrick Reimann,Verena Petzer,Axel Mündlein,Bernd Hartmann,Luciano Severgnini,Alex Winkler,Theresia Lang,Minh Huynh,Klaus Gasser, Julia Rüger,Michele Atzl,Sylvia Mink,Peter Fraunberger,Stefan Schmidt,Normann Steiner,Andrea Griesmacher,Eberhard Gunsilius,David Nachbaur,Wolfgang Willenbacher,Dominik Wolf,Thomas Winder,Magdalena Anna Benda

ANNALS OF HEMATOLOGY（2024）

Cited 0|Views25
Key words
COVID-19,Evusheld,Tixagevimab/cilgavimab,Hematological patients,Passive immunisation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined